FEBRUARY 18, 2012

Browse Categories

AUA 2009 - Bladder Cancer: Detection and Screening - Molecular Tumor Marker Tests for Bladder Cancer Screening are Influenced by Various Confounders - Interim Data of the Prospective Study UroScreen - Session Highlights

Tue, 28 April 2009  |  Christopher P. Evans, MD
E-mail Print

CHICAGO, IL, USA (UroToday.com) - This presentation was on UroScreen, a prospective study for early diagnosis of bladder cancer in 1,772 chemical workers formerly exposed to aromatic amines.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |